Newsfiscal.ai
Altimmune to Present New Pemvidutide Data at AASLD The Liver Meeting 2026
· Published
Article summary
Altimmune, Inc. announced that it will present new clinical and preclinical data for its lead product candidate, pemvidutide, at the upcoming AASLD The Liver Meeting in November 2026.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…